Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 8 pseudogene 6 (KRT8P6) is classified as a human pseudogene belonging to the keratin gene family. Pseudogenes are segments of DNA that resemble functional genes but do not encode a functional protein product due to mutations or truncations[5]. KRT8P6 is named based on its sequence similarity to the functional keratin 8 (KRT8) gene, but it is generally not transcribed or translated into a biologically active protein. Keratin pseudogenes are included in genomic classification to provide a comprehensive annotation of keratin loci, but they lack the structural or signaling functions characteristic of true keratin proteins. As such, KRT8P6 has no known physiological, pathological, or pharmacological activity and is not considered a drug target or clinically relevant biomarker[5]. If you are seeking information about therapeutically relevant keratins (such as Keratin 8 (KRT8), a cytoskeletal structural protein involved in multiple epithelial tissue functions), those are distinct from pseudogenes and would have specific roles in disease and tissue biology[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 8 pseudogene 6 (KRT8P6).